The management of peripheral blood cytopenias in systemic lupus erythematosus
Open Access
- 7 September 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 49 (12) , 2243-2254
Abstract
Haematological complications are frequently seen in SLE. Anaemia, leucopenias and thrombocytopenia may result from bone marrow failure or excessive peripheral cell destruction, both of which may be immune mediated. Drugs and infection are other common causes. In this review, we will focus on the diagnosis and management of immune-mediated leucopenias and thrombocytopenia in SLE. The roles of bone marrow examination and the measurement of antibodies against leucocytes and platelets are discussed. Although many patients do not require specific treatment for cytopenias in SLE, CSs remain the mainstay of treatment. Other conventional therapies include AZA, CYC and human normal immunoglobulin. More recently, MMF has found a role as a CS and CYC-sparing agent. We also review B-cell depletion in the management of thrombocytopenia associated with SLE and other novel therapies including thrombopoeitin receptor agonists.Keywords
This publication has 107 references indexed in Scilit:
- Potential role of IFNα in adult lupusArthritis Research & Therapy, 2010
- A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosusArthritis Care & Research, 2009
- In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2007
- Suspects in the tale of lupus-associated thrombocytopeniaClinical and Experimental Immunology, 2006
- Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolismRheumatology, 2005
- Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpuraInternational Journal of Laboratory Hematology, 2005
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004
- Autoantibodies against granulocyte colony‐stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosusArthritis & Rheumatism, 2002
- Infection and SLEAnnals of the Rheumatic Diseases, 2002
- Evaluation of Azathioprine in Autoimmune Thrombocytopenia and Lupus ErythematosusScandinavian Journal of Haematology, 1973